Immunotherapy Product Animation
Scientific Animation | Consistent Brand Identity & Scientific Education
We created this medical animation for Spectrum Pharmaceuticals for their immunotherapy product, Poziotinib®. The animation begins with the mechanism of disease of EGFR-positive and HER2-positive cancers, exploring how mutations in these genes result in uncontrolled cancer cell growth.
our approach
Poziotinib® is an investigational, orally-administered, irreversible tyrosine kinase inhibitor targeting EGFR and HER2 with exon 20 insertion mutations. Pre-clinical studies indicate that Poziotinib® inhibits kinase activity of EGFR and HER2 with exon 20 insertion mutations, inhibiting proliferation, and promoting cancer cell death. Poziotinib® is in development for the treatment of Non-Small Cell Lung Cancer (NSCLC) and breast cancer.
This animation can be found on the Spectrum Pharmaceuticals website on the Poziotinib® product page.
Imagery from the animation can be found throughout the product page. In addition, animation imagery is also used for page banners on the website homepage and the product page.
Are you interested in seeing how our scientific animation can help you?
Related work
